Klox Technologies Inc. is a private biomedical technology innovator, advancing the development and commercialization of its flagship fluorescent light energy (FLE) generating technology for regenerative medicine. Current FLE systems are commercialized under the LumiHeal®™ and Kleresca® brands. With franchises in wound care, dermatology, veterinary and oral health, Klox is well positioned to capitalize on significant market opportunities. For more information please visit www.kloxtechnologies.com
Looking for a particular Klox Technologies employee's phone or email?
The Klox Technologies annual revenue was $13.9 million in 2026.
Francesco Bellini is the CEO of Klox Technologies.
12 people are employed at Klox Technologies.
Klox Technologies is based in Laval, Quebec.
The NAICS codes for Klox Technologies are [5417, 541, 541713, 54171, 54].
The SIC codes for Klox Technologies are [873, 87].